Cargando...
RAB6C is an independent prognostic factor of estrogen receptor-positive/progesterone receptor-negative breast cancer
The majority of breast cancer tumors are estrogen receptor-positive (ER(+)) and can be treated with endocrine therapy. However, certain patients may exhibit a good prognosis without systemic treatment. The aim of the present study was to identify novel prognostic factors for patients with ER(+) brea...
Gardado en:
| Publicado en: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
D.A. Spandidos
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6923975/ https://ncbi.nlm.nih.gov/pubmed/31897114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.11109 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|